Androgens in prostate cancer: A tale that never ends

被引:28
作者
Hou, Zemin [1 ]
Huang, Shengsong [2 ]
Li, Zhenfei [1 ,2 ]
机构
[1] Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Cell Biol, CAS Ctr Excellence Mol Cell Sci,Shanghai Inst Bio, 320 Yueyang Rd, Shanghai 200031, Peoples R China
[2] Tongji Univ, Tongji Hosp, Dept Urol, Sch Med, Shanghai 200065, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Steroidogenesis; Abiraterone resistance; Enzalutamide resistance; Bipolar androgen therapy; Androgen receptor; HUMAN 3-BETA-HYDROXYSTEROID DEHYDROGENASE; DNA-BINDING DOMAIN; ABIRATERONE ACETATE; DEPRIVATION THERAPY; ANTITUMOR-ACTIVITY; INCREASED SURVIVAL; CYTOCHROME B(5); DOUBLE-BLIND; CASTRATION; RECEPTOR;
D O I
10.1016/j.canlet.2021.04.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Androgens play an essential role in prostate cancer. Clinical treatments that target steroidogenesis and the androgen receptor (AR) successfully postpone disease progression. Abiraterone and enzalutamide, the nextgeneration androgen receptor pathway inhibitors (ARPI), emphasize the function of the androgen-AR axis even in castration-resistant prostate cancer (CRPC). However, with the increased incidence in neuroendocrine prostate cancer (NEPC) showing resistance to ARPI, the importance of androgen-AR axis in further disease management remains elusive. Herein we review the steroidogenic pathways associated with different disease stages and discuss the potential targets for disease management after manifesting resistance to abiraterone and enzalutamide.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 138 条
[11]   Adrenarche - physiology, biochemistry and human disease [J].
Auchus, RJ ;
Rainey, WE .
CLINICAL ENDOCRINOLOGY, 2004, 60 (03) :288-296
[12]   Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer [J].
Auchus, RJ ;
Lee, TC ;
Miller, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3158-3165
[13]   Inhibition of rat alpha-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition [J].
Azzolina, B ;
Ellsworth, K ;
Andersson, S ;
Geissler, W ;
Bull, HG ;
Harris, GS .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 61 (1-2) :55-64
[14]  
Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095
[15]   Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans [J].
Bélanger, A ;
Pelletier, G ;
Labrie, F ;
Barbier, O ;
Chouinard, S .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (10) :473-479
[16]   Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer [J].
Beltran, Himisha ;
Prandi, Davide ;
Mosquera, Juan Miguel ;
Benelli, Matteo ;
Puca, Loredana ;
Cyrta, Joanna ;
Marotz, Clarisse ;
Giannopoulou, Eugenia ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana ;
Tomlins, Scott A. ;
Nanus, David M. ;
Tagawa, Scott T. ;
Van Allen, Eliezer M. ;
Elemento, Olivier ;
Sboner, Andrea ;
Garraway, Levi A. ;
Rubin, Mark A. ;
Demichelis, Francesca .
NATURE MEDICINE, 2016, 22 (03) :298-305
[17]   Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets [J].
Beltran, Himisha ;
Rickman, David S. ;
Park, Kyung ;
Chae, Sung Suk ;
Sboner, Andrea ;
MacDonald, Theresa Y. ;
Wang, Yuwei ;
Sheikh, Karen L. ;
Terry, Stephane ;
Tagawa, Scott T. ;
Dhir, Rajiv ;
Nelson, Joel B. ;
de la Taille, Alexandre ;
Allory, Yves ;
Gerstein, Mark B. ;
Perner, Sven ;
Pienta, Kenneth J. ;
Chinnaiyan, Arul M. ;
Wang, Yuzhuo ;
Collins, Colin C. ;
Gleave, Martin E. ;
Demichelis, Francesca ;
Nanus, David M. ;
Rubin, Mark A. .
CANCER DISCOVERY, 2011, 1 (06) :487-495
[18]   Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis [J].
Brasso, Klaus ;
Thomsen, Frederik B. ;
Schrader, Andres J. ;
Schmid, Sebastian C. ;
Lorente, David ;
Retz, Margitta ;
Merseburger, Axel S. ;
von Klot, Christoph A. ;
Boegemann, Martin ;
de Bono, Johann .
EUROPEAN UROLOGY, 2015, 68 (02) :317-324
[19]  
BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012
[20]   Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors [J].
Cai, Changmeng ;
Chen, Sen ;
Ng, Patrick ;
Bubley, Glenn J. ;
Nelson, Peter S. ;
Mostaghel, Elahe A. ;
Marck, Brett ;
Matsumoto, Alvin M. ;
Simon, Nicholas I. ;
Wang, Hongyun ;
Chen, Shaoyong ;
Balk, Steven P. .
CANCER RESEARCH, 2011, 71 (20) :6503-6513